{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:07:05Z","timestamp":1779253625319,"version":"3.51.4"},"reference-count":282,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515111199"],"award-info":[{"award-number":["2023A1515111199"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022 M713263"],"award-info":[{"award-number":["2022 M713263"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.expneurol.2026.115680","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:18:29Z","timestamp":1770682709000},"page":"115680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Phosphodiesterase 4 as a therapeutic target in Parkinson's disease recent advances"],"prefix":"10.1016","volume":"400","author":[{"given":"Jiahong","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junling","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuomiao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11882-024-01125-1","article-title":"Mast cells in aspirin-exacerbated respiratory disease","volume":"24","author":"Abud","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb0010","first-page":"390","article-title":"Research progress on phosphodiesterase 4 inhibitors in central nervous system diseases","volume":"53","author":"Adili","year":"2024","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"14","key":"10.1016\/j.expneurol.2026.115680_bb0015","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1021\/acsomega.3c10351","article-title":"Identification of novel quinolone and quinazoline alkaloids as phosphodiesterase 10A inhibitors for Parkinson\u2019s disease through a computational approach","volume":"9","author":"Ahmad","year":"2024","journal-title":"ACS Omega"},{"issue":"13","key":"10.1016\/j.expneurol.2026.115680_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells11132020","article-title":"cAMP signaling in Cancer: A PKA-CREB and EPAC-centric approach","volume":"11","author":"Ahmed","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2026.115680_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155903","article-title":"Pathological interplay of NF-kappaB and M1 macrophages in chronic inflammatory lung diseases","volume":"269","author":"Alanazi","year":"2025","journal-title":"Pathol. Res. Pract."},{"issue":"Pt 2","key":"10.1016\/j.expneurol.2026.115680_bb0030","article-title":"Targeting of AMPK\/MTOR signaling in the management of atherosclerosis: outmost leveraging","volume":"309","author":"Al-Kuraishy","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.expneurol.2026.115680_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177509","article-title":"Pharmacological landscape of endoplasmic reticulum stress: uncovering therapeutic avenues for metabolic diseases","volume":"998","author":"Alotaibi","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"40","key":"10.1016\/j.expneurol.2026.115680_bb0040","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0045","first-page":"120","article-title":"AMPK signaling pathway as a potential therapeutic target for Parkinson\u2019s disease","volume":"14","author":"Athari","year":"2024","journal-title":"Adv. Pharm. Bull"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0050","doi-asserted-by":"crossref","first-page":"21033","DOI":"10.1038\/s41598-023-48308-w","article-title":"Species-specific gill\u2019s microbiome of eight crab species with different breathing adaptations","volume":"13","author":"Bacci","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051772","article-title":"PINK1\/Parkin mediated Mitophagy, ca(2+) Signalling, and ER-mitochondria contacts in Parkinson\u2019s disease","volume":"21","author":"Barazzuol","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ph11040119","article-title":"Design, synthesis, experimental and theoretical characterization of a new multitarget 2-Thienyl-N-Acylhydrazone derivative","volume":"11","author":"Bastos","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bph.12906","article-title":"Dopamine receptors - IUPHAR review 13","volume":"172","author":"Beaulieu","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115680_bb0070","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1007\/s12035-022-02851-1","article-title":"Exploring the role of ubiquitin-proteasome system in Parkinson\u2019s disease","volume":"59","author":"Behl","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0075","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1471-4159.2010.07143.x","article-title":"Induction of the unfolded protein response by alpha-synuclein in experimental models of Parkinson\u2019s disease","volume":"116","author":"Bellucci","year":"2011","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1208\/s12248-025-01099-6","article-title":"Simplifying pharmacokinetics, applying it to drug and dosage form development, and making drug dosage decisions in clinical medicine: the adaptation of Kirchhoff\u2019s Laws from physics","volume":"27","author":"Benet","year":"2025","journal-title":"AAPS J."},{"key":"10.1016\/j.expneurol.2026.115680_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103211","article-title":"Ferroptosis in health and disease","volume":"75","author":"Berndt","year":"2024","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb0090","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41591-021-01321-w","article-title":"Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial","volume":"27","author":"Berry-Kravis","year":"2021","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.12.003","article-title":"Intersecting pathways to neurodegeneration in Parkinson\u2019s disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system","volume":"22","author":"Betarbet","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"24","key":"10.1016\/j.expneurol.2026.115680_bb0100","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1021\/acschemneuro.0c00636","article-title":"Roflumilast, a cAMP-specific Phosphodiesterase-4 inhibitor, reduces oxidative stress and improves synapse functions in human cortical neurons exposed to the Excitotoxin Quinolinic acid","volume":"11","author":"Bhat","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115680_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112692","article-title":"Neuroprotective action of agmatine in rotenone-induced model of Parkinson\u2019s disease: role of BDNF\/cREB and ERK pathway","volume":"392","author":"Bilge","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115680_bb0110","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1007\/s13555-023-01054-3","article-title":"Next generation PDE4 inhibitors that selectively target PDE4B\/D subtypes: A narrative review","volume":"13","author":"Blauvelt","year":"2023","journal-title":"Dermatol. Ther. (Heidelb.)"},{"key":"10.1016\/j.expneurol.2026.115680_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109508","article-title":"Selective PDE4B and PDE4D inhibitors produce distinct behavioral responses to ethanol and GABAergic drugs in mice","volume":"231","author":"Blednov","year":"2023","journal-title":"Neuropharmacology"},{"issue":"10291","key":"10.1016\/j.expneurol.2026.115680_bb0120","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115680_bb0125","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.cellsig.2015.08.003","article-title":"RACK1 and beta-arrestin2 attenuate dimerization of PDE4 cAMP phosphodiesterase PDE4D5","volume":"28","author":"Bolger","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.expneurol.2026.115680_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1057083","article-title":"Recent developments of phosphodiesterase inhibitors: clinical trials, emerging indications and novel molecules","volume":"13","author":"Bondarev","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5443","key":"10.1016\/j.expneurol.2026.115680_bb0135","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","article-title":"Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms","volume":"286","author":"Bonni","year":"1999","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.expneurol.2026.115680_bb0140","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1042\/BCJ20210212","article-title":"The cAMP-phosphodiesterase 4 (PDE4) controls beta-adrenoceptor- and CFTR-dependent saliva secretion in mice","volume":"478","author":"Boyd","year":"2021","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0145","first-page":"517","article-title":"Treating COPD with PDE 4 inhibitors","volume":"2","author":"Brown","year":"2007","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.expneurol.2026.115680_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152842","article-title":"Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation","volume":"61","author":"Cai","year":"2019","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb0155","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0031-6989(83)80017-4","article-title":"Therapeutic use of a selective cAMP phosphodiesterase inhibitor (Rolipram) in Parkinson\u2019s disease","volume":"15","author":"Casacchia","year":"1983","journal-title":"Pharmacol. Res. Commun."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115680_bb0160","doi-asserted-by":"crossref","first-page":"E1414","DOI":"10.1073\/pnas.1419906112","article-title":"Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4","volume":"112","author":"Cedervall","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"20","key":"10.1016\/j.expneurol.2026.115680_bb0165","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.2174\/0929867325666180226094351","article-title":"Role of autophagy in Parkinson\u2019s disease","volume":"26","author":"Cerri","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"26","key":"10.1016\/j.expneurol.2026.115680_bb0170","doi-asserted-by":"crossref","first-page":"17870","DOI":"10.1074\/jbc.M602632200","article-title":"Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells","volume":"281","author":"Chalovich","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb0175","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4161\/chan.21708","article-title":"Stimulation of arterial smooth muscle L-type calcium channels by hydrogen peroxide requires protein kinase C","volume":"6","author":"Chaplin","year":"2012","journal-title":"Channels (Austin)"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb0180","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41419-018-0722-7","article-title":"Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T alpha-synuclein model of Parkinson\u2019s disease","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.expneurol.2026.115680_bb0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainresbull.2017.11.010","article-title":"The phosphodiesterase-4 inhibitor, FCPR16, attenuates ischemia-reperfusion injury in rats subjected to middle cerebral artery occlusion and reperfusion","volume":"137","author":"Chen","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"21","key":"10.1016\/j.expneurol.2026.115680_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218376","article-title":"Apelin-13 protects dopaminergic neurons against rotenone-induced neurotoxicity through the AMPK\/mTOR\/ULK-1 mediated autophagy activation","volume":"21","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0195","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1080\/21655979.2021.1883279","article-title":"Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson's disease","volume":"12","author":"Chen","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.expneurol.2026.115680_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154125","article-title":"Alpha-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson\u2019s disease models through PKA activation","volume":"101","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"issue":"13","key":"10.1016\/j.expneurol.2026.115680_bb0205","doi-asserted-by":"crossref","first-page":"10882","DOI":"10.18632\/aging.205960","article-title":"Disorder of neuroplasticity aggravates cognitive impairment via neuroinflammation associated with intestinal flora dysbiosis in chronic heart failure","volume":"16","author":"Chen","year":"2024","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/cells14030164","article-title":"Phosphodiesterase 4 inhibition in neuropsychiatric disorders associated with Alzheimer\u2019s disease","volume":"14","author":"Chen","year":"2025","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb0215","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1007\/s12035-024-04495-9","article-title":"Inhibition of phosphodiesterase 4 suppresses neuronal Ferroptosis after cerebral ischemia\/reperfusion","volume":"62","author":"Chen","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115680_bb0220","first-page":"1841","article-title":"Exercise combined with administration of adipose-derived stem cells ameliorates neuropathic pain after spinal cord injury","volume":"18","author":"Cheng","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb0225","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2174\/0929867321666141106124657","article-title":"Microglial activation as a compelling target for treating acute traumatic brain injury","volume":"22","author":"Chio","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0230","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bbrc.2009.11.022","article-title":"AMP-activated protein kinase is activated in Parkinson\u2019s disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"391","author":"Choi","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115680_bb0235","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1523\/JNEUROSCI.5367-11.2012","article-title":"Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo","volume":"32","author":"Colla","year":"2012","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0240","article-title":"Phosphatases control the duration and range of cAMP\/PKA microdomains","volume":"6","author":"Conca","year":"2025","journal-title":"Function (Oxf)"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115680_bb0245","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbadis.2009.01.012","article-title":"A critical evaluation of the ubiquitin-proteasome system in Parkinson\u2019s disease","volume":"1792","author":"Cook","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2026.115680_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114485","article-title":"Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders","volume":"189","author":"Correia","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"15","key":"10.1016\/j.expneurol.2026.115680_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154964","article-title":"An overview of PDE4 inhibitors in clinical trials: 2010 to early 2022","volume":"27","author":"Crocetti","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb0260","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1124\/jpet.109.152454","volume":"330","author":"Davis","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb0265","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuropharm.2008.06.025","article-title":"Amelioration of recognition memory impairment associated with iron loading or aging by the type 4-specific phosphodiesterase inhibitor rolipram in rats","volume":"55","author":"de Lima","year":"2008","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115680_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261032","article-title":"Investigation of the impact of commonly used medications on the oral microbiome of individuals living without major chronic conditions","volume":"16","author":"DeClercq","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2026.115680_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102077","article-title":"Ferroptosis in Parkinson\u2019s disease: molecular mechanisms and therapeutic potential","volume":"91","author":"Ding","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2026.115680_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117009","article-title":"Beyond PDE4 inhibition: A comprehensive review on downstream cAMP signaling in the central nervous system","volume":"177","author":"Donders","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115680_bb0285","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/s41401-021-00768-4","article-title":"Roflupram protects against rotenone-induced neurotoxicity and facilitates alpha-synuclein degradation in Parkinson\u2019s disease models","volume":"42","author":"Dong","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0290","doi-asserted-by":"crossref","first-page":"19737","DOI":"10.1038\/s41598-021-98743-w","article-title":"The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP\/AMPK\/SIRT1 pathway","volume":"11","author":"Dong","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0295","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13578-024-01312-7","article-title":"Phosphodiesterase inhibition and Gucy2C activation enhance tyrosine hydroxylase Ser40 phosphorylation and improve 6-hydroxydopamine-induced motor deficits","volume":"14","author":"Douma","year":"2024","journal-title":"Cell Biosci."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0300","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/1440-1681.13231","article-title":"Inhibition of microRNA-148b-3p alleviates oxygen-glucose deprivation\/reoxygenation-induced apoptosis and oxidative stress in HT22 hippocampal neuron via reinforcing Sestrin2\/Nrf2 signalling","volume":"47","author":"Du","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb0305","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","article-title":"Tyrosine hydroxylase phosphorylation: regulation and consequences","volume":"91","author":"Dunkley","year":"2004","journal-title":"J. Neurochem."},{"issue":"22","key":"10.1016\/j.expneurol.2026.115680_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16223857","article-title":"First-line combination of R-CHOP with the PDE4 inhibitor Roflumilast for high-risk DLBCL","volume":"16","author":"Duque","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0315","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-012-1004-6","article-title":"Protein degradation pathways in Parkinson\u2019s disease: curse or blessing","volume":"124","author":"Ebrahimi-Fakhari","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0320","article-title":"Redox regulation of cAMP-dependent protein kinase and its role in health and disease","volume":"15","author":"Ekhator","year":"2025","journal-title":"Life (Basel)"},{"key":"10.1016\/j.expneurol.2026.115680_bb0325","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.938519","article-title":"Autophagy and its association with genetic mutations in Parkinson disease","volume":"28","author":"Erekat","year":"2022","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.expneurol.2026.115680_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110366","article-title":"P-CREB and p-DARPP-32 orchestrating the modulatory role of cAMP\/PKA signaling pathway enhanced by Roflumilast in rotenone-induced Parkinson\u2019s disease in rats","volume":"372","author":"Essam","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0335","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s42003-022-03029-0","article-title":"Phosphodiesterase 4D promotes angiotensin II-induced hypertension in mice via smooth muscle cell contraction","volume":"5","author":"Fan","year":"2022","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0340","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10787-023-01305-x","article-title":"PI3K\/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson's disease in rats","volume":"32","author":"Farid","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020678","article-title":"Nanosystems for brain targeting of antipsychotic drugs: an update on the most promising nanocarriers for increased bioavailability and therapeutic efficacy","volume":"15","author":"Ferreira","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb0350","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cellsig.2013.12.003","article-title":"Structural basis for the design of selective phosphodiesterase 4B inhibitors","volume":"26","author":"Fox","year":"2014","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115680_bb0355","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMoa1803583","article-title":"Phase 2 trial of Ibudilast in progressive multiple sclerosis","volume":"379","author":"Fox","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001714","article-title":"Progression of a large syphilis outbreak in rural North Carolina through space and time: application of a Bayesian maximum entropy graphical user interface","volume":"3","author":"Fox","year":"2023","journal-title":"PLOS Glob. Public Health"},{"issue":"9","key":"10.1016\/j.expneurol.2026.115680_bb0365","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2213-2600(13)70187-5","article-title":"Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials","volume":"1","author":"Franciosi","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0370","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol. Rev."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115680_bb0375","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1080\/13543784.2017.1397626","article-title":"Topical E6005\/RVT-501, a novel phosphodiesterase 4 inhibitor, for the treatment of atopic dermatitis","volume":"26","author":"Furue","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0380","doi-asserted-by":"crossref","first-page":"E459","DOI":"10.1152\/ajpendo.00120.2024","article-title":"Maintenance of thermogenic adipose tissues despite loss of the H3K27 acetyltransferases p300 or CBP","volume":"327","author":"Gamu","year":"2024","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.expneurol.2026.115680_bb0385","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bcp.2017.09.004","article-title":"The cAMP effectors PKA and Epac activate endothelial NO synthase through PI3K\/Akt pathway in human endothelial cells","volume":"145","author":"Garcia-Morales","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115680_bb0390","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/cn3000907","article-title":"Phosphodiesterases as therapeutic targets for Alzheimer\u2019s disease","volume":"3","author":"Garcia-Osta","year":"2012","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0395","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaac.2015.11.002","article-title":"The National Institute of Mental Health research domain criteria and clinical research in child and adolescent psychiatry","volume":"55","author":"Garvey","year":"2016","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115680_bb0400","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jamadermatol.2022.3862","article-title":"Association of Apremilast with vascular inflammation and cardiometabolic function in patients with psoriasis: the VIP-A phase 4, open-label, nonrandomized clinical trial","volume":"158","author":"Gelfand","year":"2022","journal-title":"JAMA Dermatol."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115680_bb0405","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/sj.emboj.7601633","article-title":"Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1\/PGC-1alpha","volume":"26","author":"Gerhart-Hines","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2026.115680_bb0410","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2147\/DDDT.S355796","article-title":"Novel liposomal Rolipram formulation for clinical application to reduce Emesis","volume":"16","author":"Gobejishvili","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.expneurol.2026.115680_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109927","article-title":"Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer\u2019s-like pathology and symptoms through multiple targeting actions in aged T2D rats","volume":"117","author":"Gomaa","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115680_bb0420","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.510","article-title":"Inhibition of phosphodiesterase 5 reduces bone mass by suppression of canonical Wnt signaling","volume":"5","author":"Gong","year":"2014","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115680_bb0425","first-page":"1775","article-title":"The interaction of alpha-synuclein with membranes and its implication in Parkinson\u2019s disease: A literature review","volume":"10","author":"Gonzalez-Horta","year":"2015","journal-title":"Nat. Prod. Commun."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0430","doi-asserted-by":"crossref","first-page":"14920","DOI":"10.1038\/s41598-024-65624-x","article-title":"Monarch butterfly conservation through male germplasm cryopreservation","volume":"14","author":"Grula","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2026.115680_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114874","article-title":"p38 MAPK-DRP1 signaling is involved in mitochondrial dysfunction and cell death in mutant A53T alpha-synuclein model of Parkinson\u2019s disease","volume":"388","author":"Gui","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0440","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-kappaB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.expneurol.2026.115680_bb0445","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-025-05001-5","article-title":"Exploring the connection between BDNF\/TrkB and AC\/cAMP\/PKA\/CREB signaling pathways: potential for neuroprotection and therapeutic targets for neurological disorders","author":"Gupta","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0450","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s13311-014-0309-7","article-title":"Phosphodiesterase-4 (PDE4) molecular pharmacology and Alzheimer's disease","volume":"12","author":"Gurney","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.expneurol.2026.115680_bb0455","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1021\/acs.jmedchem.9b00193","article-title":"Design and synthesis of selective phosphodiesterase 4D (PDE4D) allosteric inhibitors for the treatment of fragile X syndrome and other brain disorders","volume":"62","author":"Gurney","year":"2019","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.expneurol.2026.115680_bb0460","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1016\/j.bmcl.2014.06.002","article-title":"Discovery of triazines as selective PDE4B versus PDE4D inhibitors","volume":"24","author":"Hagen","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.expneurol.2026.115680_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105560","article-title":"Conditional disruption of AMP kinase in dopaminergic neurons promotes Parkinson\u2019s disease-associated phenotypes in vivo","volume":"161","author":"Hang","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.115680_bb0470","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6137521","article-title":"Oxidative stress and Neuroinflammation potentiate each other to promote progression of dopamine neurodegeneration","volume":"2020","author":"He","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb0475","article-title":"Advancing treatment in atopic dermatitis: A comprehensive review of clinical efficacy, safety, and comparative insights into corticosteroids, Calcineurin inhibitors, and Phosphodiesterase-4 inhibitors as topical therapies","volume":"16","author":"Hernandez","year":"2024","journal-title":"Cureus"},{"issue":"23","key":"10.1016\/j.expneurol.2026.115680_bb0480","doi-asserted-by":"crossref","first-page":"13693","DOI":"10.1021\/acs.chemrev.3c00479","article-title":"Parkinson\u2019s disease: advances in treatment and the syntheses of various classes of pharmaceutical drug substances","volume":"123","author":"Hill","year":"2023","journal-title":"Chem. Rev."},{"issue":"1\u20133","key":"10.1016\/j.expneurol.2026.115680_bb0485","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2007.06.045","article-title":"Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain","volume":"573","author":"Hirose","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0490","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/emboj\/18.4.893","article-title":"The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579","volume":"18","author":"Hoffmann","year":"1999","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0495","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1038\/s41598-023-37041-z","article-title":"A hybrid multifunctional physicochemical sensor suite for continuous monitoring of crop health","volume":"13","author":"Hossain","year":"2023","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115680_bb0500","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","article-title":"Autophagy in Parkinson\u2019s disease","volume":"432","author":"Hou","year":"2020","journal-title":"J. Mol. Biol."},{"issue":"Pt 1","key":"10.1016\/j.expneurol.2026.115680_bb0505","first-page":"1","article-title":"PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization","volume":"370","author":"Houslay","year":"2003","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0510","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1042\/bst0250374","article-title":"Intracellular targeting, interaction with Src homology 3 (SH3) domains and rolipram-detected conformational switches in cAMP-specific PDE4A phosphodiesterase","volume":"25","author":"Houslay","year":"1997","journal-title":"Biochem. Soc. Trans."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0515","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/BCJ20160849","article-title":"Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners","volume":"474","author":"Houslay","year":"2017","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115680_bb0520","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/aps.2016.88","article-title":"Ferulic acid prevents LPS-induced up-regulation of PDE4B and stimulates the cAMP\/CREB signaling pathway in PC12 cells","volume":"37","author":"Huang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.expneurol.2026.115680_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110653","article-title":"Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K\/Akt signaling pathway","volume":"124","author":"Huang","year":"2019","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.expneurol.2026.115680_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156652","article-title":"Apigenin enhances Nrf2-induced chaperone-mediated autophagy and mitigates alpha-synuclein pathology: implications for Parkinson\u2019s disease therapy","volume":"141","author":"Huang","year":"2025","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115680_bb0535","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/j.1460-9568.1995.tb01041.x","article-title":"Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivo","volume":"7","author":"Hulley","year":"1995","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb0540","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1089\/jamp.2019.1528","article-title":"Detrimental effects of an inhaled Phosphodiesterase-4 inhibitor on lung inflammation in ventilated preterm lambs exposed to Chorioamnionitis are dose dependent","volume":"32","author":"Hutten","year":"2019","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100351","article-title":"Portosinusoidal vascular disorder: A heretofore unrecognized manifestation of sickle cell disease?","volume":"37","author":"Jafari","year":"2024","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0550","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12031-013-0208-0","article-title":"EPO-dependent activation of PI3K\/Akt\/FoxO3a signalling mediates neuroprotection in in vitro and in vivo models of Parkinson\u2019s disease","volume":"53","author":"Jia","year":"2014","journal-title":"J. Mol. Neurosci."},{"issue":"21","key":"10.1016\/j.expneurol.2026.115680_bb0555","doi-asserted-by":"crossref","first-page":"11998","DOI":"10.1073\/pnas.96.21.11998","article-title":"Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice","volume":"96","author":"Jin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"14","key":"10.1016\/j.expneurol.2026.115680_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411518","article-title":"PDE4 inhibitors: profiling hits through the multitude of structural classes","volume":"24","author":"Jin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.115680_bb0565","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fphar.2020.00609","article-title":"Respiratory cilia as a therapeutic target of phosphodiesterase inhibitors","volume":"11","author":"Joskova","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"19","key":"10.1016\/j.expneurol.2026.115680_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191912414","article-title":"The impact of airline\u2019s smart work system on job performance of cabin crew","volume":"19","author":"Jung","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.xplc.2025.101299","article-title":"Ferroptosis in plant immunity","volume":"6","author":"Jwa","year":"2025","journal-title":"Plant Commun."},{"key":"10.1016\/j.expneurol.2026.115680_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103092","article-title":"Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS\/RNS: relevance to Parkinson\u2019s disease and therapeutic implications","volume":"71","author":"Kalyanaraman","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.expneurol.2026.115680_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson\u2019s disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115680_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253547","article-title":"Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan","volume":"16","author":"Karasawa","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2026.115680_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1529756","article-title":"Epigenetic regulation of transcription factors involved in NLRP3 inflammasome and NF-kB signaling pathways","volume":"16","author":"Kaszycki","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb0600","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/annrheumdis-2013-205056","article-title":"Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor","volume":"73","author":"Kavanaugh","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0605","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jphs.2017.04.002","article-title":"Rolipram improves facilitation of contextual fear extinction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson\u2019s disease","volume":"134","author":"Kinoshita","year":"2017","journal-title":"J. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb0610","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/09546634.2018.1530439","article-title":"Pharmacokinetic disposition of topical phosphodiesterase-4 inhibitor E6005 in patients with atopic dermatitis","volume":"30","author":"Kitahara","year":"2019","journal-title":"J. Dermatolog. Treat."},{"issue":"14","key":"10.1016\/j.expneurol.2026.115680_bb0615","doi-asserted-by":"crossref","first-page":"11859","DOI":"10.1074\/jbc.M108808200","article-title":"Zinc inhibition of cAMP signaling","volume":"277","author":"Klein","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115680_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073367","article-title":"Parkinson\u2019s disease: the neurodegenerative enigma under the \u201cundercurrent\u201d of endoplasmic reticulum stress","volume":"26","author":"Kong","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0625","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00213-011-2436-8","article-title":"Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor\/PKA\/DARPP-32 signaling cascade in frontal cortex","volume":"219","author":"Kuroiwa","year":"2012","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115680_bb0630","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00011-005-1386-1","article-title":"The inhibitory effects of roflumilast on lipopolysaccharide-induced nitric oxide production in RAW264.7 cells are mediated by heme oxygenase-1 and its product carbon monoxide","volume":"54","author":"Kwak","year":"2005","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb0635","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cellsig.2007.12.011","article-title":"PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways","volume":"20","author":"Kwak","year":"2008","journal-title":"Cell. Signal."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115680_bb0640","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2022.15632","article-title":"Effect of Roflumilast cream vs vehicle cream on chronic plaque psoriasis: the DERMIS-1 and DERMIS-2 randomized clinical trials","volume":"328","author":"Lebwohl","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.expneurol.2026.115680_bb0645","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainres.2015.09.029","article-title":"Silibinin suppresses astroglial activation in a mouse model of acute Parkinson\u2019s disease by modulating the ERK and JNK signaling pathways","volume":"1627","author":"Lee","year":"2015","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb0650","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ygyno.2019.11.031","article-title":"Assessment of clinical performance of an ultrasensitive nanowire assay for detecting human papillomavirus DNA in urine","volume":"156","author":"Lee","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb0655","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1152\/ajpendo.00156.2023","article-title":"Endoplasmic reticulum stress in pancreatic beta cells induces incretin desensitization and beta-cell dysfunction via ATF4-mediated PDE4D expression","volume":"325","author":"Lee","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.expneurol.2026.115680_bb0660","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.115680_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113958","article-title":"DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling","volume":"177","author":"Li","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.115680_bb0670","article-title":"Targeting microglial alpha-Synuclein\/TLRs\/NF-kappaB\/NLRP3 Inflammasome Axis in Parkinson\u2019s disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2026.115680_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115195","article-title":"Advances in the development of phosphodiesterase-4 inhibitors","volume":"250","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.expneurol.2026.115680_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177230","article-title":"The phosphodiesterase-4 inhibitor Zl-n-91 suppresses glioblastoma growth via EGR1\/PTEN\/AKT pathway","volume":"988","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb0685","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1021\/acs.jmedchem.0c00060","article-title":"Discovery and optimization of alpha-Mangostin derivatives as novel PDE4 inhibitors for the treatment of vascular dementia","volume":"63","author":"Liang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0690","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12017-023-08755-0","article-title":"The role of ubiquitin-proteasome system and Mitophagy in the pathogenesis of Parkinson\u2019s disease","volume":"25","author":"Liang","year":"2023","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.expneurol.2026.115680_bb0695","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1186\/1471-2091-8-S1-S13","article-title":"Role of the ubiquitin proteasome system in Parkinson\u2019s disease","volume":"8 Suppl 1(Suppl 1)","author":"Lim","year":"2007","journal-title":"BMC Biochem."},{"key":"10.1016\/j.expneurol.2026.115680_bb0700","article-title":"Topical application of anthranilate derivatives ameliorates psoriatic inflammation in a mouse model by inhibiting keratinocyte-derived chemokine expression and neutrophil infiltration","author":"Lin","year":"2018","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0705","first-page":"2773","article-title":"Various subtypes of phosphodiesterase inhibitors differentially regulate pulmonary vein and sinoatrial node electrical activities","volume":"19","author":"Lin","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.expneurol.2026.115680_bb0710","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.2147\/JIR.S465630","article-title":"2% Crisaborole ointment for the treatment of chronic Cheilitis caused by lip tattoos","volume":"17","author":"Liu","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00538","article-title":"Fibrinogen degradation products exacerbate alpha-synuclein aggregation by inhibiting autophagy via downregulation of Beclin1 in multiple system atrophy","volume":"22","author":"Liu","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"52","key":"10.1016\/j.expneurol.2026.115680_bb0720","doi-asserted-by":"crossref","first-page":"E7176","DOI":"10.1073\/pnas.1522332112","article-title":"cAMP-induced phosphorylation of 26S proteasomes on Rpn6\/PSMD11 enhances their activity and the degradation of misfolded proteins","volume":"112","author":"Lokireddy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2026.115680_bb0725","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biopha.2016.11.077","article-title":"Quercetin attenuates high fructose feeding-induced atherosclerosis by suppressing inflammation and apoptosis via ROS-regulated PI3K\/AKT signaling pathway","volume":"85","author":"Lu","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0730","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12974-025-03396-5","article-title":"Protective role of mitophagy on microglia-mediated neuroinflammatory injury through mtDNA-STING signaling in manganese-induced parkinsonism","volume":"22","author":"Lu","year":"2025","journal-title":"J. Neuroinflammation"},{"issue":"15","key":"10.1016\/j.expneurol.2026.115680_bb0735","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158052","article-title":"PDE4D: A multipurpose pharmacological target","volume":"25","author":"Lusardi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb0740","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00011-022-01676-x","article-title":"Role of alpha-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson\u2019s disease","volume":"72","author":"Lv","year":"2023","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.expneurol.2026.115680_bb0745","article-title":"Mitochondrial quality control and transfer communication in neurological disorders and neuroinflammation","volume":"16","author":"Ma","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115680_bb0750","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-kappaB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0755","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00210-001-0525-7","article-title":"Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site","volume":"365","author":"Martin","year":"2002","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.115680_bb0760","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2147\/COPD.S226688","article-title":"Inhaled dual phosphodiesterase 3\/4 inhibitors for the treatment of patients with COPD: A short review","volume":"16","author":"Martin","year":"2021","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0765","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.expneurol.2012.08.008","article-title":"Ubiquitin proteasome system in Parkinson\u2019s disease: a keeper or a witness?","volume":"238","author":"Martins-Branco","year":"2012","journal-title":"Exp. Neurol."},{"issue":"13","key":"10.1016\/j.expneurol.2026.115680_bb0770","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1111\/febs.70059","article-title":"A PDE4 shortform degrader: a first in isoform-specific PDE4 inhibition","volume":"292","author":"Maurice","year":"2025","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40744-014-0005-4","article-title":"Apremilast: A phosphodiesterase 4 inhibitor for the treatment of psoriatic arthritis","volume":"1","author":"Mease","year":"2014","journal-title":"Rheumatol Ther"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb0780","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molmed.2012.12.005","article-title":"An ERcentric view of Parkinson\u2019s disease","volume":"19","author":"Mercado","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.expneurol.2026.115680_bb0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106889","article-title":"Alpha-Synuclein pathology and mitochondrial dysfunction: toxic partners in Parkinson\u2019s disease","volume":"209","author":"Mingo","year":"2025","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1012233","article-title":"GEM-based computational modeling for exploring metabolic interactions in a microbial community","volume":"20","author":"Mirzaei","year":"2024","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0795","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-017-0154-3","article-title":"Therapeutic potential of autophagy-enhancing agents in Parkinson\u2019s disease","volume":"12","author":"Moors","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2026.115680_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.101954","article-title":"Endoplasmic reticulum stress: A key player in immune cell regulation and autoimmune disorders","volume":"78","author":"Moreews","year":"2025","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0805","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchemneu.2010.03.004","article-title":"The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D","volume":"40","author":"Mori","year":"2010","journal-title":"J. Chem. Neuroanat."},{"issue":"10423","key":"10.1016\/j.expneurol.2026.115680_bb0810","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"issue":"5809","key":"10.1016\/j.expneurol.2026.115680_bb0815","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1126\/science.1127085","article-title":"Proteasome-independent functions of ubiquitin in endocytosis and signaling","volume":"315","author":"Mukhopadhyay","year":"2007","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0820","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm.4011","article-title":"Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling","volume":"22","author":"Myeku","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2026.115680_bb0825","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.nbd.2018.12.008","article-title":"Following spinal cord injury, PDE4B drives an acute, local inflammatory response and a chronic, systemic response exacerbated by gut dysbiosis and endotoxemia","volume":"124","author":"Myers","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0830","doi-asserted-by":"crossref","first-page":"16487","DOI":"10.1038\/s41598-024-65735-5","article-title":"Delivery of CDNF by AAV-mediated gene transfer protects dopamine neurons and regulates ER stress and inflammation in an acute MPTP mouse model of Parkinson\u2019s disease","volume":"14","author":"Nam","year":"2024","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115680_bb0835","doi-asserted-by":"crossref","DOI":"10.3390\/biom13101435","article-title":"Autophagy in Parkinson\u2019s disease","volume":"13","author":"Nechushtai","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb0840","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1212\/WNL.0000000000004201","article-title":"Loss of phosphodiesterase 4 in Parkinson disease: relevance to cognitive deficits","volume":"89","author":"Niccolini","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0845","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12035-013-8483-x","article-title":"The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson\u2019s disease: focus on astrocytes","volume":"49","author":"Niranjan","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"42","key":"10.1016\/j.expneurol.2026.115680_bb0850","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1523\/JNEUROSCI.2518-08.2008","article-title":"Distinct roles of PDE4 and PDE10A in the regulation of cAMP\/PKA signaling in the striatum","volume":"28","author":"Nishi","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0855","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11033-024-09484-8","article-title":"Targeting phosphodiesterase 4 as a potential therapy for Parkinson\u2019s disease: a review","volume":"51","author":"Nongthombam","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115680_bb0860","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1056\/NEJM198603133141102","article-title":"Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia","volume":"314","author":"Ordovas","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.expneurol.2026.115680_bb0865","article-title":"Proteomic identification of small extracellular vesicle proteins LAMB1 and histone H4 for prostate Cancer diagnosis and risk stratification","volume":"11","author":"Pang","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0870","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2015.03.049","article-title":"Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: results of a phase III, randomized, controlled trial (efficacy and safety trial evaluating the effects of Apremilast in psoriasis [ESTEEM] 1)","volume":"73","author":"Papp","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115680_bb0875","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s12272-020-01281-8","article-title":"Ubiquitin-proteasome system (UPS) as a target for anticancer treatment","volume":"43","author":"Park","year":"2020","journal-title":"Arch. Pharm. Res."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb0880","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253269","article-title":"Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis","volume":"16","author":"Park","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0885","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12929-023-00961-z","article-title":"Neuroprotective effects of osmotin in Parkinson\u2019s disease-associated pathology via the AdipoR1\/MAPK\/AMPK\/mTOR signaling pathways","volume":"30","author":"Park","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0890","doi-asserted-by":"crossref","DOI":"10.3390\/cells14020086","article-title":"Modulation of second messenger signaling in the brain through PDE4 and PDE5 inhibition: therapeutic implications for neurological disorders","volume":"14","author":"Park","year":"2025","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0895","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1358\/dot.2017.53.4.2604174","article-title":"Crisaborole: phosphodiesterase inhibitor for treatment of atopic dermatitis","volume":"53","author":"Paton","year":"2017","journal-title":"Drugs Today (Barc.)"},{"issue":"10","key":"10.1016\/j.expneurol.2026.115680_bb0900","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/glia.22986","article-title":"PDE4B as a microglia target to reduce neuroinflammation","volume":"64","author":"Pearse","year":"2016","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0905","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1476-5381.2010.01035.x","article-title":"Inhibition of cyclooxygenase-2 prevents adverse effects induced by phosphodiesterase type 4 inhibitors in rats","volume":"162","author":"Peter","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.115680_bb0910","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2020.00259","article-title":"Inhaled phosphodiesterase 4 (PDE4) inhibitors for inflammatory respiratory diseases","volume":"11","author":"Phillips","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115680_bb0915","article-title":"Mitochondrial dysfunction, oxidative stress, and Neuroinflammation: intertwined roads to neurodegeneration","volume":"9","author":"Picca","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0920","doi-asserted-by":"crossref","first-page":"603","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115680_bb0925","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070703","article-title":"Neuroinflammation in ischemic stroke: inhibition of cAMP-specific Phosphodiesterases (PDEs) to the rescue","volume":"9","author":"Ponsaerts","year":"2021","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.expneurol.2026.115680_bb0930","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092229","article-title":"Alpha-Synuclein decreases the abundance of proteasome subunits and alters ubiquitin conjugates in yeast","volume":"10","author":"Popova","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2026.115680_bb0935","doi-asserted-by":"crossref","DOI":"10.3389\/fspor.2024.1421363","article-title":"New model of sports tourism with sustainable tourism development to increase tourist arrivals in Central Aceh regency, Indonesia","volume":"6","author":"Rangkuti","year":"2024","journal-title":"Front Sports Act Living"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb0940","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3904\/kjim.2020.035","article-title":"Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease","volume":"35","author":"Rhee","year":"2020","journal-title":"Korean J. Intern. Med."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115680_bb0945","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1517\/14728222.2013.818656","article-title":"PDE4 as a target for cognition enhancement","volume":"17","author":"Richter","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb0950","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202409027","article-title":"Intersection of GPCR trafficking and cAMP signaling at endomembranes","volume":"224","author":"Ripoll","year":"2025","journal-title":"J. Cell Biol."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115680_bb0955","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI0215506","article-title":"Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis","volume":"110","author":"Robichaud","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb0960","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/hep.30761","article-title":"Phosphodiesterase 4 inhibition as a therapeutic target for alcoholic liver disease: from bedside to bench","volume":"70","author":"Rodriguez","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb0965","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s10571-023-01349-1","article-title":"Phosphodiesterase-4 inhibition in Parkinson\u2019s disease: molecular insights and therapeutic potential","volume":"43","author":"Roy","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0970","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/1061186X.2024.2408724","article-title":"Roflumilast-loaded nanostructured lipid carriers attenuate oxidative stress and neuroinflammation in Parkinson\u2019s disease model","volume":"33","author":"Roy","year":"2025","journal-title":"J. Drug Target."},{"key":"10.1016\/j.expneurol.2026.115680_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112854","article-title":"New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases","volume":"209","author":"Rucilova","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb0980","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12974-018-1337-8","article-title":"Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4","volume":"15","author":"Russo","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.expneurol.2026.115680_bb0985","article-title":"MRI findings in a rare case of left-sided obstructed Hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome in a 21-year-old female","volume":"15","author":"Saifi","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.expneurol.2026.115680_bb0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107858","article-title":"Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities","volume":"226","author":"Samidurai","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2026.115680_bb0995","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jchemneu.2012.12.005","article-title":"Critical role for PDE4 subfamilies in the development of experimental autoimmune encephalomyelitis","volume":"47","author":"Sanabra","year":"2013","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.expneurol.2026.115680_bb1000","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuro.2017.05.009","article-title":"Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes","volume":"64","author":"Sarkar","year":"2018","journal-title":"Neurotoxicology"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115680_bb1005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182019","article-title":"The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson's disease","volume":"12","author":"Schwenkgrub","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.expneurol.2026.115680_bb1010","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1080\/07391102.2024.2308764","article-title":"Targeting PDE4A for therapeutic potential: exploiting drug repurposing approach through virtual screening and molecular dynamics","volume":"43","author":"Shamsi","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb1015","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.130217","article-title":"CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases","volume":"4","author":"Sharma","year":"2014","journal-title":"Open Biol."},{"key":"10.1016\/j.expneurol.2026.115680_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2025.104023","article-title":"Rethinking Parkinson\u2019s: the role of proteostasis networks and autophagy in disease progression","volume":"134","author":"Sharma","year":"2025","journal-title":"Mol. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb1025","doi-asserted-by":"crossref","DOI":"10.3390\/cells14060460","article-title":"Role of PDE4 family in cardiomyocyte physiology and heart failure","volume":"14","author":"Sherstnev","year":"2025","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.expneurol.2026.115680_bb1030","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.7150\/thno.104709","article-title":"Microglial circDlg1 modulates neuroinflammation by blocking PDE4B ubiquitination-dependent degradation associated with Alzheimer's disease","volume":"15","author":"Shi","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.expneurol.2026.115680_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105903","article-title":"PDE4D inhibitors: opening a new era of PET diagnostics for Alzheimer\u2019s disease","volume":"182","author":"Shi","year":"2025","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2026.115680_bb1040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","article-title":"NF-kappaB signaling pathways in neurological inflammation: A Mini review","volume":"8","author":"Shih","year":"2015","journal-title":"Front. Mol. Neurosci."},{"issue":"13","key":"10.1016\/j.expneurol.2026.115680_bb1045","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1111\/febs.17359","article-title":"Targeted protein degradation of PDE4 shortforms by a novel proteolysis targeting chimera","volume":"292","author":"Sin","year":"2025","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115680_bb1050","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","article-title":"Role of nuclear factor kappa B (NF-kappaB) Signalling in neurodegenerative diseases: an mechanistic approach","volume":"18","author":"Singh","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.expneurol.2026.115680_bb1055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2016.06.011","article-title":"A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients","volume":"40","author":"Singh","year":"2016","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"14","key":"10.1016\/j.expneurol.2026.115680_bb1060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147679","article-title":"IRE1\/JNK is the leading UPR pathway in 6-OHDA-induced degeneration of differentiated SH-SY5Y cells","volume":"25","author":"Siwecka","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb1065","first-page":"2695","article-title":"The mitochondrial foundations of Parkinson\u2019s disease: therapeutic implications","volume":"16","author":"Soman","year":"2025","journal-title":"Aging Dis."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115680_bb1070","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.neuron.2025.03.028","article-title":"Alpha-synuclein mutations mislocalize cytoplasmic p300 compromising autophagy, which is rescued by ACLY inhibition","volume":"113","author":"Son","year":"2025","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb1075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12264-018-0209-7","article-title":"Iron, dopamine, and alpha-Synuclein interactions in at-risk dopaminergic neurons in Parkinson\u2019s disease","volume":"34","author":"Song","year":"2018","journal-title":"Neurosci. Bull."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb1080","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051556","article-title":"Pre-clinical assessment of Roflumilast therapy in a thoracic model of spinal cord injury","volume":"15","author":"Sousa","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb1085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/1357650X.2024.2377633","article-title":"Fear is more right lateralized than happiness and anger: evidence for the motivational hypothesis of emotional face perception?","volume":"29","author":"Speranza","year":"2024","journal-title":"Laterality"},{"issue":"36","key":"10.1016\/j.expneurol.2026.115680_bb1090","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.2174\/138161208786898653","article-title":"Subtype selectivity in phosphodiesterase 4 (PDE4): a bottleneck in rational drug design","volume":"14","author":"Srivani","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.expneurol.2026.115680_bb1095","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fimmu.2016.00238","article-title":"Pharmacologic inhibition of host Phosphodiesterase-4 improves isoniazid-mediated clearance of mycobacterium tuberculosis","volume":"7","author":"Subbian","year":"2016","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb1100","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1253\/circj.CJ-20-0302","article-title":"Coronavirus disease 2019 (COVID-19) information for cardiologists - systematic literature review and additional analysis","volume":"84","author":"Sugimoto","year":"2020","journal-title":"Circ. J."},{"issue":"21","key":"10.1016\/j.expneurol.2026.115680_bb1105","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/0006-2952(87)90004-9","article-title":"Effect of flutamide on hepatic cytosolic methyltrienolone (R1881) binding kinetics and testosterone responsive hepatic drug and steroid metabolism in the adult male rat","volume":"36","author":"Sunahara","year":"1987","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb1110","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tins.2007.03.008","article-title":"D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons","volume":"30","author":"Surmeier","year":"2007","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb1115","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson\u2019s disease","volume":"391","author":"Tanner","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb1120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coph.2007.09.010","article-title":"Ubiquitin-proteasome system as a modulator of cell fate","volume":"8","author":"Thompson","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb1125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2009.09.055","article-title":"Akt signal transduction dysfunction in Parkinson\u2019s disease","volume":"467","author":"Timmons","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"45","key":"10.1016\/j.expneurol.2026.115680_bb1130","doi-asserted-by":"crossref","first-page":"44405","DOI":"10.1074\/jbc.M308041200","article-title":"Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function","volume":"278","author":"Tofaris","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115680_bb1135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fnmol.2018.00165","article-title":"Simvastatin inhibits activation of NADPH oxidase\/p38 MAPK pathway and enhances expression of antioxidant protein in Parkinson disease models","volume":"11","author":"Tong","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115680_bb1140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.freeradbiomed.2015.08.008","article-title":"Osthol attenuates neutrophilic oxidative stress and hemorrhagic shock-induced lung injury via inhibition of phosphodiesterase 4","volume":"89","author":"Tsai","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb1145","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70133","article-title":"Oxidative\/Nitrosative stress, apoptosis, and redox signaling: key players in neurodegenerative diseases","volume":"39","author":"Uremis","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"5659","key":"10.1016\/j.expneurol.2026.115680_bb1150","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115680_bb1160","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson\u2019s disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"issue":"35","key":"10.1016\/j.expneurol.2026.115680_bb1165","doi-asserted-by":"crossref","first-page":"12815","DOI":"10.1073\/pnas.0707715105","article-title":"Executioner caspase-3 and caspase-7 are functionally distinct proteases","volume":"105","author":"Walsh","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb1170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10930-025-10264-x","article-title":"Endoplasmic reticulum stress: implications in diseases","volume":"44","author":"Walter","year":"2025","journal-title":"Protein J."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb1175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2014.08.004","article-title":"Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson\u2019s disease: involvement of ERK1\/2-Nrf2 signaling pathway","volume":"114","author":"Wang","year":"2014","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb1180","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/s41467-024-48348-4","article-title":"Halide perovskite inducing anomalous nonvolatile polarization in poly(vinylidene fluoride)-based flexible nanocomposites","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb1185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10571-025-01575-9","article-title":"Endoplasmic reticulum stress inhibition promotes Mitophagy via Miro1 reduction to rescue mitochondrial dysfunction and protect dopamine neurons in Parkinson\u2019s disease","volume":"45","author":"Wen","year":"2025","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2026.115680_bb1190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.parkreldis.2019.02.027","article-title":"The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson\u2019s disease","volume":"77","author":"Wilson","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb1195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuint.2013.05.006","article-title":"p38(MAPK)\/p53-mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson\u2019s disease","volume":"63","author":"Wu","year":"2013","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb1200","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/cdd.2015.135","article-title":"C-Abl-p38alpha signaling plays an important role in MPTP-induced neuronal death","volume":"23","author":"Wu","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2026.115680_bb1205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.phrs.2016.11.002","article-title":"Hederagenin and alpha-hederin promote degradation of proteins in neurodegenerative diseases and improve motor deficits in MPTP-mice","volume":"115","author":"Wu","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115680_bb1210","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10571-019-00745-w","article-title":"Inhibition of PDE4 attenuates TNF-alpha-triggered cell death through suppressing NF-kappaB and JNK activation in HT-22 neuronal cells","volume":"40","author":"Xiao","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115680_bb1215","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4161\/auto.6685","article-title":"Alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson\u2019s disease pathogenesis","volume":"4","author":"Xilouri","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2026.115680_bb1220","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bcp.2019.02.023","article-title":"FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia\/reperfusion injury through activation of the AKT\/GSK3beta\/ beta-catenin signaling pathway","volume":"163","author":"Xu","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.115680_bb1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101342","article-title":"Inhibition of PDE4 protects neurons against oxygen-glucose deprivation-induced endoplasmic reticulum stress through activation of the Nrf-2\/HO-1 pathway","volume":"28","author":"Xu","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.expneurol.2026.115680_bb1230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.freeradbiomed.2020.12.018","article-title":"Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3beta-mediated oxidative stress and IRE1alpha\/TRAF2\/JNK pathway","volume":"163","author":"Xu","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb1235","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1038\/s41598-025-87639-8","article-title":"PDE4B promotes ferroptosis in nucleus pulposus cells and is involved in intervertebral disc degeneration","volume":"15","author":"Xu","year":"2025","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115680_bb1240","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1128\/IAI.02213-14","article-title":"DAP1, a negative regulator of autophagy, controls SubAB-mediated apoptosis and autophagy","volume":"82","author":"Yahiro","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.expneurol.2026.115680_bb1245","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110743","article-title":"The neuroprotective effect of schisandrol A on 6-OHDA-induced PD mice may be related to PI3K\/AKT and IKK\/IkappaBalpha\/NF-kappaB pathway","volume":"128","author":"Yan","year":"2019","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb1250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"20","key":"10.1016\/j.expneurol.2026.115680_bb1255","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.1523\/JNEUROSCI.18-20-08145.1998","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2","volume":"18","author":"Yang","year":"1998","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb1260","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.expneurol.2007.02.010","article-title":"Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV","volume":"211","author":"Yang","year":"2008","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb1265","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00357","article-title":"A phosphodiesterase 4 (PDE4) inhibitor, amlexanox, reduces neuroinflammation and neuronal death after pilocarpine-induced seizure","volume":"21","author":"Yang","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb1270","doi-asserted-by":"crossref","DOI":"10.3390\/biom15060847","article-title":"Stress management: how the endoplasmic reticulum mitigates protein Misfolding and oxidative stress by the dual role of glutathione peroxidase 8","volume":"15","author":"Yang","year":"2025","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb1275","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.semcdb.2012.02.006","article-title":"Regulation of gene expression by the ubiquitin-proteasome system","volume":"23","author":"Yao","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"issue":"16","key":"10.1016\/j.expneurol.2026.115680_bb1280","article-title":"The \u201cleafing intensity premium\u201d hypothesis and the scaling relationships of the functional traits of bamboo species","volume":"13","author":"Yao","year":"2024","journal-title":"Plants (Basel)"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb1285","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/13543784.2025.2510671","article-title":"Safety, pharmacokinetics, and efficacy of HY-072808 ointment, a novel PDE4 inhibitor, in adolescent and adult patients with mild-to-moderate AD","volume":"34","author":"Yao","year":"2025","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb1290","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13055","article-title":"Tau inhibits PKA by nuclear proteasome-dependent PKAR2alpha elevation with suppressed CREB\/GluA1 phosphorylation","volume":"19","author":"Ye","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.expneurol.2026.115680_bb1295","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson\u2019s syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.expneurol.2026.115680_bb1300","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.2147\/DDDT.S507489","article-title":"AMPK in intestinal health and disease: A multifaceted therapeutic target for metabolic and inflammatory disorders","volume":"19","author":"Yibcharoenporn","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115680_bb1305","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1021\/acschemneuro.7b00065","article-title":"Roflupram, a phosphodiesterase 4 Inhibitior, suppresses Inflammasome activation through autophagy in microglial cells","volume":"8","author":"You","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115680_bb1310","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/2327-6924.12428","article-title":"Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic disease","volume":"28","author":"Young","year":"2016","journal-title":"J. Am. Assoc. Nurse Pract."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115680_bb1315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022354","article-title":"Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. Elegans","volume":"6","author":"Yuan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2026.115680_bb1320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fphar.2019.00016","article-title":"Canthin-6-one accelerates alpha-Synuclein degradation by enhancing UPS activity: drug target identification by CRISPR-Cas9 whole genome-wide screening technology","volume":"10","author":"Yuan","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3 Suppl 1","key":"10.1016\/j.expneurol.2026.115680_bb1325","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jaad.2017.11.056","article-title":"Phosphodiesterase 4 inhibitors","volume":"78","author":"Zebda","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115680_bb1330","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s10753-024-02156-6","article-title":"Interplay of alpha-Synuclein oligomers and endoplasmic reticulum stress in Parkinson\u2019S disease: insights into cellular dysfunctions","volume":"48","author":"Zeng","year":"2025","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb1335","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11064-025-04348-4","article-title":"The interplay between endoplasmic reticulum stress and Ferroptosis in neurological diseases","volume":"50","author":"Zhai","year":"2025","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb1340","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00213-006-0369-4","article-title":"Antidepressant-like effects of PDE4 inhibitors mediated by the high-affinity rolipram binding state (HARBS) of the phosphodiesterase-4 enzyme (PDE4) in rats","volume":"186","author":"Zhang","year":"2006","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.expneurol.2026.115680_bb1345","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.apsb.2021.02.016","article-title":"Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb1350","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3892\/etm.2021.10834","article-title":"Roflumilast, a type of phosphodiesterase 4 inhibitor, can reduce intestinal injury caused by sepsis","volume":"22","author":"Zhang","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115680_bb1355","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/cns.13807","article-title":"Inhibition of phosphodiesterase-4 in the spinal dorsal horn ameliorates neuropathic pain via cAMP-cytokine-Cx43 signaling in mice","volume":"28","author":"Zhang","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2026.115680_bb1360","article-title":"Phosphodiesterase 4B (PDE4B) inhibitors and their applications in recent years (2014 to early 2025)","author":"Zhang","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.expneurol.2026.115680_bb1365","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2023.111946","article-title":"cAMP\/PKA signaling promotes AKT deactivation by reducing CIP2A expression, thereby facilitating decidualization","volume":"571","author":"Zhao","year":"2023","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115680_bb1370","doi-asserted-by":"crossref","DOI":"10.3390\/ph17060782","article-title":"Exploring the role of ubiquitin-proteasome system in the pathogenesis of Parkinson\u2019s disease","volume":"17","author":"Zhao","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"Pt 1","key":"10.1016\/j.expneurol.2026.115680_bb1375","article-title":"Therapeutic potential and limitation of condensed and hydrolyzed tannins in Parkinson\u2019s disease","volume":"307","author":"Zhao","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115680_bb1380","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00031.2024","article-title":"Ferroptosis: when metabolism meets cell death","volume":"105","author":"Zheng","year":"2025","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.expneurol.2026.115680_bb1385","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.redox.2018.02.008","article-title":"Inhibition of phosphodiesterase 4 by FCPR16 protects SH-SY5Y cells against MPP(+)-induced decline of mitochondrial membrane potential and oxidative stress","volume":"16","author":"Zhong","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.expneurol.2026.115680_bb1390","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2019.02.027","article-title":"Inhibition of PDE4 by FCPR16 induces AMPK-dependent autophagy and confers neuroprotection in SH-SY5Y cells and neurons exposed to MPP(+)-induced oxidative insult","volume":"135","author":"Zhong","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2026.115680_bb1395","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pnpbp.2018.10.017","article-title":"FCPR16, a novel phosphodiesterase 4 inhibitor, produces an antidepressant-like effect in mice exposed to chronic unpredictable mild stress","volume":"90","author":"Zhong","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.expneurol.2026.115680_bb1400","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/bph.14983","article-title":"Roflupram exerts neuroprotection via activation of CREB\/PGC-1alpha signalling in experimental models of Parkinson\u2019s disease","volume":"177","author":"Zhong","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.115680_bb1405","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115859","article-title":"Roflupram attenuates alpha-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant alpha-synuclein","volume":"436","author":"Zhong","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.115680_bb1410","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2016.08.052","article-title":"Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings","volume":"124","author":"Zhou","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115680_bb1415","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1124\/jpet.116.239608","article-title":"Novel phosphodiesterase 4 inhibitor FCPR03 alleviates lipopolysaccharide-induced Neuroinflammation by regulation of the cAMP\/PKA\/CREB signaling pathway and NF-kappaB inhibition","volume":"362","author":"Zou","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:10:50Z","timestamp":1779250250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":282,"alternative-id":["S0014488626000439"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115680","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphodiesterase 4 as a therapeutic target in Parkinson's disease recent advances","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115680"}}